Thomas Christott graduated with a Diploma in Biology (technologically oriented) from the University of Stuttgart, Germany in 2012. He joined ProImmune, Ltd. in Oxford from 2012 to 2015 as an assay scientist, working with the REVEAL and ProVE T-cell epitope discovery platforms as well as their protein purification pipeline.
In July 2015, he returned to the fold of academia and joined the Screening group at the Target Discovery Institute.
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function
Fagan V. et al, (2019), Journal of Medicinal Chemistry
Discovery of a Potent and Selective Fragment-like Inhibitor of Methyllysine Reader Protein Spindlin 1 (SPIN1)
Xiong Y. et al, (2019), Journal of Medicinal Chemistry
Discovery of an MLLT1/3 YEATS Domain Chemical Probe
Moustakim M. et al, (2018), Angewandte Chemie International Edition, 57, 16302 - 16307
Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9.
Christott T. et al, (2018), SLAS Discov
Development of a YEATS-domain chemical probe
Moustakim M. et al, (2018), ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 256